Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies
2023-01-26 08:11
Singleron launches single cell eQTL analysis as part of their sequencing service
2023-01-25 19:00
Complete Genomics to Announce New Product Launches at AGBT General Meeting
2023-01-24 20:30
CARsgen Presents Results on Anti-Claudin18.2-mAb AB011 at ASCO GI
2023-01-20 21:50
SK bioscience Appoints New Executives to Accelerate New Growth Strategies
2023-01-20 20:00
DualityBio Announces DB-1303 Granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) for the Treatment of Advanced, Recurrent or Metastatic Endometrial Carcinoma with HER2 Overexpression
2023-01-20 18:00
BriSTAR Immunotech To Present its Novel Cell Therapy for Acute Myeloid Leukemia at the AACR Special Conference on AML and MDS
2023-01-20 13:10
$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases
2023-01-20 09:50
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS
2023-01-20 02:00
Hepagene Therapeutics Reports Positive Top-line Results for Phase 2a RISE Study of FXR Agonist HPG1860 in Patients with NASH
2023-01-19 23:00
Tigermed Completes Acquisition of Marti Farm
2023-01-19 14:59
China's First and Only Approved Third-Generation BCR-ABL Inhibitor Olverembatinib Included into the 2022 National Reimbursement Drug List
2023-01-19 11:45
Keymed Biosciences | The Latest Results from the Phase Ia Clinical Study of CMG901 was presented at the 2023 ASCO GI CANCERS SYMPOSIUM
2023-01-18 09:52
IASO Bio Raises Nearly $75 Million in Series C1 Funding
2023-01-18 08:00
Asieris Appoints Dr. Linda Wu as Chief Development Officer
2023-01-18 07:00
Tanso Biosciences Expands Its Line-up with 250 Mouse GPCRs
2023-01-18 00:00
FDA Accepts GMP Plasmid DMF of OBiO Technology
2023-01-17 08:00
FAPON presents at 41st Annual J.P. Morgan Healthcare Conference
2023-01-16 22:09
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China
2023-01-16 18:00
SD Biosensor Successfully Finishes JP Morgan Healthcare Conference
2023-01-13 15:11
1
62
63
64
65
66
222